Transplantation of the Liver,3/e(Expert Consult - Online and Print) > General Surgery

I: Considerations

1. History of Liver and Multivisceral Transplantation

2. Surgical Anatomy of the Liver

3. Molecular and Cellular Basics of Hepatic Failure

4. Influence of Transplantation on Liver Surgery

5. Liver Allocation: The US Model

6. Liver Allocation: The European Models

7. Donation After Brain Death or Cardiac Death: Regulatory and Ethical Principles

II: Patient Evaluation: Adult

8. Current Indications, Contraindications, De-listing Criteria and Timing for Transplantation

9. Transplantation for Hepatitis A and B

10. Natural History of Hepatitis C

11. Hepatitis C and Transplantation

12. Transplantation for Fulminant Hepatic Failure

13. Transplantation for Primary Biliary Cirrhosis

14. Transplantation for Sclerosing Cholangitis

15. Transplantation for Autoimmune Hepatitis

16. Transplantation for Hepatocellular Carcinoma

17. Transplantation for Cholangiocarcinoma

18. Transplantation for Metastases of the Liver

19. Transplantation for Hematological Disorders

20. Transplantation for Budd-Chiari Syndrome

21. Transplantation for Alcoholic Liver Disease

22. Transplantation for NASH

23. Unusual Indications for Transplantation

III: Patient Evaluation: Pediatric

24. General Criteria for Pediatric Transplantation

25. Transplantation for Cholestatic Liver Disease

26. Transplantation for Biliary Atresia

27. Transplantation for Metabolic Disease

28. Transplantation for Hepatic Malignancy

IV: Special Considerations in Patient Evaluation

29. Ethical Decisions in Transplantation

30. The Psychiatric Assessment of Liver Transplant Candidates

31. Pretransplantation Evaluation: Cardiac

32. Pretransplantation Evaluation: Renal

33. Pretransplantation Infectious Disease Screening for Candidates and Donors

34. Clinical Nurse Coordinator: Nursing Focus on Care of Patients with End-Stage Liver Disease

35. Radiologic Evaluation in the Transplant Patient

36. Monitoring and Care of the Patient Before Transplantation

37. Nutritional Aspects of Adult Transplantation

38. Management of Portal Hypertensive Hemorrhage

39. Portopulmonary Hypertension and Hepatopulmonary Syndrome

V: Operation

40. Donor Selection and Management

41. Exted Criteria Donors

42. Non-Heart Beating Donors

43. Donor Operations

44. Principles of Preservation

45. Recipient Hepatectomy and Grafting

46. Anesthesia for Transplantation

VI: Split and Living Donor Transplantation

47. Imaging Techniques for Partial Grafting

48. Living Related Transplantation in Pediatric Recipients

49. Donor and Recipient Evaluation and Selection for Adult-to-Adult Transplantation

50. Adult Living Donor Right Hepatectomy and Recipient Operation

51. Adult Living Donor Left Hepatectomy and Recipient Operation

52. Split Liver Transplantation for the Pediatric and Adult Recipients

53. Split Liver Transplantation for Two Adults

54. Best Techniques for Biliary and Vascular Reconstruction in Living Donor Transplantation

55. Small for Size Syndrome

56. Minimally Invasive Living Donor Hepatectomy

57. Dual Grafts for Transplantation

58. Outcomes of Living Donor Transplantation: Western Perspective

59. Outcomes of Living Donor Transplantation: Eastern Perspective

60. Ethics of Living Donor Transplantation

VII: Unusual Operative Problems

61. Arterial Reconstructions - Pitfalls

62. Portal Vein Thrombosis and Other Venous Anomalies in Liver Transplantation

63. Combined Liver-Kidney Transplantation

64. Retransplantation

65. Clinical Management of Necrotic Liver During Transplantation

66. Transplantation with Digestive Organs

67. Transplantation and Situs Inversus

68. Auxiliary Transplants

VIII: Postoperative Care

69. Postoperative Intensive Care Management in Adults

70. Postoperative Intensive Care Management in Children

71. Postoperative Management Beyond the Intensive Care Unit: Adults

72. Postoperative Care of Pediatric Transplant Recipients

73. Transition of Pediatric Patients to Adulthood

74. Renal Failure in Adult Transplant Recipients

75. Graft Failure: Etiology, Recognition, and Treatment

76. Technical Problems: Biliary

77. Management of Arterial Complications after Transplantation

78. Infections After Transplantation

79. Recurrent Hepatitis C

80. Late Complications and Recurrence of Disease

81. Neuropsychiatric Outcomes in Recipients

82. Postoperative Neurological Disorders and Prognosis

83. Role of the Posttransplantation Coordinator

IX: Transplant Pathology

84. Histological Patterns of Rejection and Other Causes of Dysfunction

85. Pathology of Recurrence of Non-Neoplastic Disease After Transplantation

86. Transplant Related Malignancies

X: Immunology of Liver Transplantation

87. Rejection After Transplantation

88. Cell Migration, Chimerism, and Graft Acceptance

89. ABO, Tissue Typing, and Crossmatching Incompatibility

90. GVHD after Transplantation

XI: Immunosuppression

91. Induction and Maintenance of Immunosuppression

92. Special Considerations for Pediatric Immunosuppression After Transplantation

93. Treatment of Acute and Chronic Rejection

94. Novel Immunosuppression of Patients with Hepatic Malignancies

95. Non-Biologic New Immunosuppressive Drugs

96. Immunosuppressive Biologic Agents

97. Long-term Toxicity of Immunosuppressive Therapy

XII: Survival and Results

98. Outcome Predictors in Transplantation

99. U.S. Trs in Transplantation: 1988-Present

100. Long-term Functional Recovery and Quality of Life: Childhood, Adulthood, Employment, Pregnancy, and Family Planning

101. Results: Survival and Quality of Life after Transplantation in Children

XIII: Future Developments in Liver Transplantation

102. Genetic and Genomic Potentials in Transplantation

103. Xenotransplantation

104. Hepatocyte Transplantation

105. Stem Cell and Liver Regeneration

106. Ischemia-Reperfusion Injury

107. Extracorporeal Perfusion for Resuscitation of Marginal Grafts

108. Extracorporeal Xenogeneic Support

109. Development of Bioartificial Liver